In Phase A, participants will obtain different doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. More members will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Phase C, contributors https://abbv-744brd4inhibitioninc78013.izrablog.com/32489109/detailed-notes-on-abbv-744-brd4-inhibitor-mechanism-of-action